Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$817K Hold
15,210
0.9% 23
2017
Q3
$929K Sell
15,210
-52
-0.3% -$3.15K 1.06% 24
2017
Q2
$933K Hold
15,262
1.11% 23
2017
Q1
$925K Buy
15,262
+145
+1% +$8.8K 1.19% 22
2016
Q4
$849K Buy
+15,117
New +$885K 1.16% 22
2016
Q1
Sell
-6,761
Closed -$341K 60
2015
Q4
$341K Sell
6,761
-1,535
-19% -$77.4K 0.44% 47
2015
Q3
$391K Sell
8,296
-5,455
-40% -$290K 0.4% 52
2015
Q2
$747K Sell
13,751
-1,960
-12% -$110K 0.5% 38
2015
Q1
$862K Buy
15,711
+4,798
+44% +$272K 0.55% 38
2014
Q4
$591K Buy
10,913
+281
+3% +$15.7K 0.36% 56
2014
Q3
$601K Buy
10,632
+231
+2% +$13K 0.4% 47
2014
Q2
$574K Buy
10,401
+1,425
+16% +$77.7K 0.37% 49
2014
Q1
$486K Buy
8,976
+838
+10% +$43.4K 0.34% 52
2013
Q4
$389K Sell
8,138
-2,745
-25% -$125K 0.27% 62
2013
Q3
$494K Hold
10,883
0.36% 45
2013
Q2
$482K Buy
+10,883
New +$486K 0.35% 45

Other funds holding MRK

Independence Trust's MRK Position: Q4 2017 in Review

Independence Trust held its Merck (MRK) position steady in Q4 2017 at 15,210 shares worth $817K. The position accounts for 0.9% of the portfolio, ranked #23.

Independence Trust first reported a position in MRK in Q2 2013 and has held it in 16 quarters since. The position peaked at $933K in Q2 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Independence Trust held 15,210 shares of Merck worth $817K as of Q4 2017.
  • Independence Trust left its Merck share count unchanged in Q4 2017.
  • Merck made up 0.9% of Independence Trust's portfolio in Q4 2017, its #23 holding.
  • Independence Trust first reported a position in Merck in Q2 2013 and has held it in 16 quarters since.
  • Independence Trust's Merck position peaked at $933K in Q2 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Independence Trust's 13F filing for Q4 2017, filed 8 Feb 2018.